Phosphodiesterase type-5 inhibitors for erectile dysfunction following nerve-sparing radical prostatectomy

Volume: 100, Issue: 8, Pages: e23778 - e23778
Published: Feb 26, 2021
Abstract
To verify which phosphodiesterase type 5 inhibitors (PDE5is) strategy is better for erectile dysfunction (ED) following nerve-sparing radical prostatectomy (NSRP).This systematic literature search was conducted in MEDLINE, Web of Science and Cochrane Central Register of Controlled Trials database to identify eligible studies from the startup of these databases to 1 November, 2019. The ED recovery rate was the main outcome. Traditional pair-wise...
Paper Details
Title
Phosphodiesterase type-5 inhibitors for erectile dysfunction following nerve-sparing radical prostatectomy
Published Date
Feb 26, 2021
Journal
Volume
100
Issue
8
Pages
e23778 - e23778
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.